Unknown

Dataset Information

0

Mindfulness-Based Program Plus Amygdala and Insula Retraining (MAIR) for the Treatment of Women with Fibromyalgia: A Pilot Randomized Controlled Trial.


ABSTRACT: The lack of highly effective treatments for fibromyalgia (FM) represents a great challenge for public health. The objective of this parallel, pilot randomized controlled trial (RCT) was two-fold: (1) to analyze the clinical effects of mindfulness plus amygdala and insula retraining (MAIR) compared to a structurally equivalent active control group of relaxation therapy (RT) in the treatment of FM; and (2) to evaluate its impact on immune-inflammatory markers and brain-derived neurotrophic factor (BDNF) in serum. A total of 41 FM patients were randomized into two study arms: MAIR (intervention group) and RT (active control group), both as add-ons of treatment as usual. MAIR demonstrated significantly greater reductions in functional impairment, anxiety, and depression, as well as higher improvements in mindfulness, and self-compassion at post-treatment and follow-up, with moderate to large effect sizes. Significant decreases in pain catastrophizing and psychological inflexibility and improvements in clinical severity and health-related quality of life were found at follow-up, but not at post-treatment, showing large effect sizes. The number needed to treat was three based on the criteria of ?50% Fibromyalgia Impact Questionnaire (FIQ) reduction post-treatment. Compared to RT, the MAIR showed significant decreases in BDNF. No effect of MAIR was observed in immune-inflammatory biomarkers (i.e., TNF-?, IL-6, IL-10, and hs-CRP). In conclusion, these results suggest that MAIR, as an adjuvant of treatment-as-usual (TAU), appears to be effective for the management of FM symptoms and for reducing BDNF levels in serum.

SUBMITTER: Sanabria-Mazo JP 

PROVIDER: S-EPMC7599726 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mindfulness-Based Program Plus Amygdala and Insula Retraining (MAIR) for the Treatment of Women with Fibromyalgia: A Pilot Randomized Controlled Trial.

Sanabria-Mazo Juan P JP   Montero-Marin Jesus J   Feliu-Soler Albert A   Gasión Virginia V   Navarro-Gil Mayte M   Morillo-Sarto Héctor H   Colomer-Carbonell Ariadna A   Borràs Xavier X   Tops Mattie M   Luciano Juan V JV   García-Campayo Javier J  

Journal of clinical medicine 20201011 10


The lack of highly effective treatments for fibromyalgia (FM) represents a great challenge for public health. The objective of this parallel, pilot randomized controlled trial (RCT) was two-fold: (1) to analyze the clinical effects of mindfulness plus amygdala and insula retraining (MAIR) compared to a structurally equivalent active control group of relaxation therapy (RT) in the treatment of FM; and (2) to evaluate its impact on immune-inflammatory markers and brain-derived neurotrophic factor  ...[more]

Similar Datasets

| S-EPMC5568071 | biostudies-other
| S-EPMC4975795 | biostudies-literature
| S-EPMC8708843 | biostudies-literature
| S-EPMC7168768 | biostudies-literature
| S-EPMC7564648 | biostudies-literature
| S-EPMC6060839 | biostudies-other
2017-08-10 | GSE85506 | GEO
| S-EPMC8572138 | biostudies-literature
| S-EPMC9291217 | biostudies-literature
| S-EPMC5962606 | biostudies-literature